Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension
David Kylhammar, Barbro Kjellström, Clara Hjalmarsson, et al.
European Heart Journal (2017) Vol. 39, Iss. 47, pp. 4175-4181
Closed Access | Times Cited: 475

Showing 1-25 of 475 citing articles:

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert, Gábor Kovács, Marius M. Hoeper, et al.
European Heart Journal (2022) Vol. 43, Iss. 38, pp. 3618-3731
Open Access | Times Cited: 2102
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert, Gábor Kovács, Marius M. Hoeper, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 1, pp. 2200879-2200879
Open Access | Times Cited: 1177
Risk stratification and medical therapy of pulmonary arterial hypertension
Nazzareno Galiè, Richard N. Channick, Robert P. Frantz, et al.
European Respiratory Journal (2018) Vol. 53, Iss. 1, pp. 1801889-1801889
Open Access | Times Cited: 741
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
Marius M. Hoeper, Tilmann Kramer, Zixuan Pan, et al.
European Respiratory Journal (2017) Vol. 50, Iss. 2, pp. 1700740-1700740
Open Access | Times Cited: 596
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
Erika B. Rosenzweig, Steven H. Abman, Ian Adatia, et al.
European Respiratory Journal (2018) Vol. 53, Iss. 1, pp. 1801916-1801916
Open Access | Times Cited: 516
Predicting Survival in Patients With Pulmonary Arterial Hypertension
Raymond L. Benza, Mardi Gomberg‐Maitland, C. Gregory Elliott, et al.
CHEST Journal (2019) Vol. 156, Iss. 2, pp. 323-337
Open Access | Times Cited: 510
Pulmonary Arterial Hypertension
Paul M. Hassoun
New England Journal of Medicine (2021) Vol. 385, Iss. 25, pp. 2361-2376
Closed Access | Times Cited: 411
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Marc Humbert, Vallerie V. McLaughlin, J. Simon R. Gibbs, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 13, pp. 1204-1215
Open Access | Times Cited: 373
Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension
Raymond L. Benza, Manreet Kanwar, Amresh Raina, et al.
CHEST Journal (2020) Vol. 159, Iss. 1, pp. 337-346
Open Access | Times Cited: 218
Pulmonary Hypertension: A Brief Guide for Clinicians
Stacy A. Mandras, Hirsch Mehta, Anjali Vaidya
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 9, pp. 1978-1988
Open Access | Times Cited: 213
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension
Marius M. Hoeper, Christine Pausch, Karen M. Olsson, et al.
European Respiratory Journal (2021) Vol. 60, Iss. 1, pp. 2102311-2102311
Open Access | Times Cited: 205
Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension
Marius M. Hoeper, Raymond L. Benza, Paul A. Corris, et al.
European Respiratory Journal (2018) Vol. 53, Iss. 1, pp. 1801906-1801906
Open Access | Times Cited: 189
Clinical trial design and new therapies for pulmonary arterial hypertension
Olivier Sitbon, Mardi Gomberg‐Maitland, John Granton, et al.
European Respiratory Journal (2018) Vol. 53, Iss. 1, pp. 1801908-1801908
Open Access | Times Cited: 172
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
Marius M. Hoeper, Christine Pausch, Ekkehard Grünig, et al.
The Journal of Heart and Lung Transplantation (2020) Vol. 39, Iss. 12, pp. 1435-1444
Open Access | Times Cited: 155
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension
Athénaïs Boucly, Laurent Savale, Xavier Jaïs, et al.
American Journal of Respiratory and Critical Care Medicine (2021) Vol. 204, Iss. 7, pp. 842-854
Open Access | Times Cited: 142
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry
Athénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 6, pp. 2102419-2102419
Open Access | Times Cited: 136
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 573-584
Closed Access | Times Cited: 125
Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry
Kevin Y. Chang, Sue Duval, David B. Badesch, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 9
Open Access | Times Cited: 118
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
Marius M. Hoeper, Krit Dwivedi, Christine Pausch, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 10, pp. 937-948
Open Access | Times Cited: 109
Treatment algorithm for pulmonary arterial hypertension
Kelly Chin, Seán Gaine, Christian Gerges, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401325-2401325
Open Access | Times Cited: 24
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension
Junichi Omura, Karima Habbout, Tsukasa Shimauchi, et al.
Circulation (2020) Vol. 142, Iss. 15, pp. 1464-1484
Open Access | Times Cited: 127
Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension
Michele D’Alto, Roberto Badagliacca, Paola Argiento, et al.
CHEST Journal (2019) Vol. 157, Iss. 2, pp. 376-383
Closed Access | Times Cited: 126
Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension
Robert A. Lewis, Christopher Johns, Marcella Cogliano, et al.
American Journal of Respiratory and Critical Care Medicine (2019) Vol. 201, Iss. 4, pp. 458-468
Open Access | Times Cited: 124
Phosphodiesterase 5 inhibitors for pulmonary hypertension
Hayley Barnes, Zoe Brown, Andrew Burns, et al.
Cochrane library (2019) Vol. 2019, Iss. 3
Open Access | Times Cited: 116
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
Clara Hjalmarsson, Göran Rådegran, David Kylhammar, et al.
European Respiratory Journal (2018) Vol. 51, Iss. 5, pp. 1702310-1702310
Open Access | Times Cited: 106
Page 1 - Next Page

Scroll to top